ELAMIPRETIDE IN PATIENTS WITH BARTH SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL FOLLOWED BY 36-WEEK OPEN-LABEL EXTENSION

Authors:
  • RTReid Thompson
    Reid Thompson
  • RMRyan Manuel
    Ryan Manuel
  • AAAnthony Aiudi
    Anthony Aiudi
  • JJJohn J. Jones
    John J. Jones
  • JCJim Carr
    Jim Carr
  • BHBrittany Hornby
    Brittany Hornby
  • HVHilary Vernon
    Hilary Vernon

Abstract
No abstract available